MAO-B inhibitors for the treatment of Parkinson's disease.
Identifieur interne : 003986 ( PubMed/Curation ); précédent : 003985; suivant : 003987MAO-B inhibitors for the treatment of Parkinson's disease.
Auteurs :Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2002.
English descriptors
- KwdEn :
- Humans, Monoamine Oxidase (metabolism), Monoamine Oxidase Inhibitors (adverse effects), Monoamine Oxidase Inhibitors (pharmacology), Monoamine Oxidase Inhibitors (therapeutic use), Parkinson Disease (drug therapy), Randomized Controlled Trials as Topic, Selegiline (adverse effects), Selegiline (pharmacology), Selegiline (therapeutic use).
- MESH :
- chemical , adverse effects : Monoamine Oxidase Inhibitors, Selegiline.
- chemical , metabolism : Monoamine Oxidase.
- chemical , pharmacology : Monoamine Oxidase Inhibitors, Selegiline.
- chemical , therapeutic use : Monoamine Oxidase Inhibitors, Selegiline.
- drug therapy : Parkinson Disease.
- Humans, Randomized Controlled Trials as Topic.
DOI: 10.1002/mds.5559
PubMed: 12211138
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003986
Links to Exploration step
pubmed:12211138Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">MAO-B inhibitors for the treatment of Parkinson's disease.</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12211138</idno>
<idno type="pmid">12211138</idno>
<idno type="doi">10.1002/mds.5559</idno>
<idno type="wicri:Area/PubMed/Corpus">003986</idno>
<idno type="wicri:Area/PubMed/Curation">003986</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">MAO-B inhibitors for the treatment of Parkinson's disease.</title>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term>
<term>Monoamine Oxidase (metabolism)</term>
<term>Monoamine Oxidase Inhibitors (adverse effects)</term>
<term>Monoamine Oxidase Inhibitors (pharmacology)</term>
<term>Monoamine Oxidase Inhibitors (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Selegiline (adverse effects)</term>
<term>Selegiline (pharmacology)</term>
<term>Selegiline (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Monoamine Oxidase Inhibitors</term>
<term>Selegiline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Monoamine Oxidase</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Monoamine Oxidase Inhibitors</term>
<term>Selegiline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Monoamine Oxidase Inhibitors</term>
<term>Selegiline</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">12211138</PMID>
<DateCreated><Year>2002</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2007</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>17 Suppl 4</Volume>
<PubDate><Year>2002</Year>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>MAO-B inhibitors for the treatment of Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>S38-44</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008996">Monoamine Oxidase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>14611-51-9</RegistryNumber>
<NameOfSubstance UI="D012642">Selegiline</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.4.3.4</RegistryNumber>
<NameOfSubstance UI="D008995">Monoamine Oxidase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008995">Monoamine Oxidase</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008996">Monoamine Oxidase Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012642">Selegiline</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>28</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12211138</ArticleId>
<ArticleId IdType="doi">10.1002/mds.5559</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003986 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003986 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:12211138 |texte= MAO-B inhibitors for the treatment of Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:12211138" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |